EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Photodynamic therapy of head and neck squamous cell carcinoma optical dosimetry and clinical trial


Photochemistry & Photobiology 46(5): 911-918
Photodynamic therapy of head and neck squamous cell carcinoma optical dosimetry and clinical trial
This paper reports the retrospective comparison of a PDT dosimetry model with the current results of an ongoing clinical trial on photodynamic therapy (PDT) for head and neck squamous cell carcinoma (HNSCC). The model is based on the assumption that tumor eradication requires a minimum absorption of radiant therapy by the tumor-localized porphyrins. The diffusion approximation was employed to calculate the incident light dose required to attain the minimum absorbed energy density at tumor boundaries most distant from the light source. Dosimetry tables for HNSCC were calculated with estimated tissue parameters, giving the PDT light dose for front surface exposure (FS) and illumination by interstitial cylindrical diffuser fibers (CI) in terms of the tumor dimensions. The model includes a correction for the photobleaching of the localized photosensitizer by the therapeutic light. The PDT trial was carried out on nine patients with previously untreated or recurrent early stage tumors and one patient with a recurrent advanced stage tumor. A complete response was obtained in 83% (10/12) of the sites treated. The calculated doses for FS and CI exposures vary from comparable with no three-fold lowe than the actual doses for each complete response tumor site.

Accession: 006110671

PMID: 3327063

DOI: 10.1111/j.1751-1097.1987.tb04868.x

Download PDF Full Text: Photodynamic therapy of head and neck squamous cell carcinoma optical dosimetry and clinical trial



Related references

Interstitial photodynamic therapy with rotating and reciprocating optical fibers: Clinical trial of three patients with squamous cell carcinoma of the tongue. Cancer 91(9): 1791-1796, May 1, 2001

Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Archives of Otolaryngology--Head & Neck Surgery 116(11): 1267-1270, 1990

Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan. Hno 56(4): 402-409, 2007

Photodynamic therapy with Foscan in primary squamous cell carcinoma of the head and neck. European Journal of Cancer 37(Supplement 6): S38-S39, October, 2001

Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future. Lasers in Medical Science 30(9): 2381-2387, 2016

Photodynamic therapy using m-THPC (Foscan). Treatment of head and neck squamous cell carcinoma. Hno 56(5): 490-492, 2008

Neutron therapy for squamous cell carcinoma of the head and neck the 5 year follow up of the edinburgh scotland uk randomized clinical trial. British Journal of Cancer 61(1): 157, 1990

Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck; results from a randomized clinical trial. International Journal of Radiation Oncology Biology Physics 24(SUPPL 1): 239-240, 1992

Efficacy of postoperative radiation therapy for squamous cell carcinoma of the head and neck: results of a prospective randomised clinical trial. Acta Otorrinolaringologica Espanola 55(9): 415-419, 2004

Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial. Cancer Immunology, ImmunoTherapy 56(9): 1397-1406, 2007